Chief Financial Officer. As President at Lexaria Bioscience Corp., John Docherty made $195,740 in total compensation. John Docherty — President and Director. The new contracts last for three years and will allow the Kelowna, British Columbia-based company to make sure its senior team stays in place at a time when its business is growing … By: “Chris Bunka” Chris Bunka, CEO “ASSIGNOR” LEXARIA BIOSCIENCE CORP. By: “John Docherty” By: “Chris Bunka” John Docherty, President . Ed Ergenzinger. Presently, John Martin Docherty is President & Director at Lexaria Bioscience Corp. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada. Test Your Cannabis IQ Here, Best Way To Clean Your Oil/Wax Vaporizer Pen. John was formerly President and COO of … Mr. Docherty was former President and Chief Operating officer of Helix BioPharma Corp. (TSX: HBP), where he led the company’s pharmaceutical development programs for its plant and recombinantly derived therapeutic protein product candidates. As President at Lexaria Bioscience Corp., John Docherty made $195,740 in total compensation. CIVILIZED: How did you get into the cannabis space? I joined Lexaria at that time because I immediately recognized the potential of its formulation technology for enabling effective oral cannabinoid delivery, and the implications this had for helping people to better access the incredible benefits of cannabis. Lexaria’s technology is designed to achieve exactly this, having been shown in both in vitro laboratory and human focus studies to deliver cannabinoid effectiveness in as little as 15 minutes, and to consistently magnify potency by as much as 5-10 fold so that the consumer experiences predictable and timely benefits. Presently, John Martin Docherty is President & Director at Lexaria Bioscience Corp. “Lexaria’s proprietary drug delivery platform has already proven its effectiveness in the oral delivery of other lipophilic drugs such as nicotine, cannabinoids, and more, with multi-fold increases in both the rate and extent of bioabsorption,” said John Docherty, President of Lexaria Bioscience Corp. Kelowna, BC, V1X2P7, General Disclaimer: Welcome to C-Suite, our new interview series with business leaders in the cannabis industry. John Martin Docherty is President & Director at Lexaria Bioscience Corp. View John Martin Docherty’s professional profile on Relationship Science, the database of decision makers. I frequently run into people from my former mainstream pharmaceutical and biopharmaceutical world who have or are considering making the transition. I personally enjoy our own ViPova™ and LexariaEnergyFoods brands of full spectrum hemp oil infused products on a regular basis as an important part of my commitment to health and wellness. Probably the regulatory aspects that are obviously evolving constantly. Lexaria's technology, Dehydratech, allows cannabidiol (CBD) and other oils to be dehydrated into an odorless, tasteless powder and mixed with xanthan gum, corn flour and other base ingredients which can then be added to foods, drinks and creams. I am obviously biased toward edible consumption with our enabling technology as a convenient, healthy and effective mode of administration. John became President of Lexaria in the Spring of 2015 and joined its board of directors a year later. Do you see any big changes coming in the future of cannabis? Yes, absolutely, some of which are positive and some are not. NATIONAL RESEARCH COUNCIL AND LEXARIA BIOSCIENCE COMMENCE LABORATORY WORK Lexaria Bioscience Corp. has started laboratory work under its collaborative research program with the National Research Council of Canada (NRC) following the completion of preparation initiatives announced on March 14, 2017. Get Lexaria Bioscience Corp (LEXX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The cannabis sector is witnessing exponential advancement in the application of technology industry-wide at all levels. No statement in this web site has been evaluated by the Food and Drug Administration (FDA). Lexaria is investigating whether its technology might be useful for more effectively delivering drugs in the fight against certain viruses including SARS-CoV-2 that causes COVID-19. There are so many strains of marijuana available it can be nearly impossible to figure out which one is right for you. Our goal is to align with industry partners on an international scale and power a new generation of healthful consumer products by solving the delivery challenges that have limited this until technology like ours became available. Lexaria Biosciences and Altria ... for enhancing the palatability and speed of onset of orally-consumed bioactive substances such as nicotine," added John Docherty, President of Lexaria Bioscience The new contracts last for three years and will allow the company to make sure its senior team stays in place in the near-term Below is our interview with John Docherty, President at Lexaria Bioscience Corp. (OTC: LXRP; OTCMKTS: LXRPD), which produces hemp-infused foods for consumers with active lifestyles. In addition, our technology has been shown to markedly improve flavor profiles without the need to use unwanted and unhealthy sweeteners to offset the bitter flavoring of cannabinoid extracts. John became President of Lexaria in the Spring of 2015 and joined its board of directors a year later. Allan Spissinger. Extraction and distillation equipment is already in wide use in order to purify individual molecules for later recombination. What is the most frustrating aspect of the cannabis industry today? We live in exciting times where researchers around the globe are ever-increasingly recognizing the power of the human endocannabinoid system and the potential to benefit human health and wellness through supplementing its effects through the use of cannabis and its derivatives. "Lexaria Bioscience has repeatedly demonstrated the powerful effects of its patented DehydraTECH™ technology for enhancing the palatability and speed of onset of orally-consumed bioactive substances such as nicotine," added John Docherty, President of Lexaria Bioscience. Lexaria Bioscience Corp.'s proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. ... At Lexaria, Mr. Docherty heads up new product/technology research and development and also serves as a key spokesperson for the company liaising with new and existing shareholders, strategic partners and the … Our technology is designed to make it possible to deliver bioactive substances including, but not limited to, cannabinoids in foods and other consumer product formats with faster action and greater potency than ever before. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. Both Lexaria and I personally are focused on new technology development and optimization. Lexaria Bioscience Corp. (CSE:LXX; NASDAQ:LEXX) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules. I personally believe that the next biggest wave in healthcare management will be growth in the functional food and consumer goods sector, and this is where Lexaria Bioscience is poised to make its most significant commercial impacts. John Docherty at Post War English & Scottish Football League A–Z Player's Database; John Docherty management career statistics at Soccerbase This page was last edited on 18 January 2021, at 13:58 (UTC). KELOWNA, BC / ACCESSWIRE / June 24, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria") announces the results of the 2020 Annual and Special Meeting (the "Meeting"). View the profiles of professionals named "John Docherty" on LinkedIn. Lexaria Bioscience Corp. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria Bioscience Corp. LEXX Stock Message Board: Interesting? "It is with tremendous pleasure that I join Lexaria as President," said Mr. Docherty. Mr. Docherty was former President and Chief Operating officer of Helix BioPharma Corp. (TSX: HBP), where he led the company’s pharmaceutical development programs for its plant and recombinantly derived therapeutic protein product candidates. He is a named inventor on issued and pending patents and he has a M.Sc. (Add your “underperform” vote.) Chris Bunka, CEO John Docherty, M.Sc. View John Docherty's business profile as President & Chief Scientist at Lexaria Bioscience. He has worked with large multinational companies, as well as emerging private and publicly-traded start-ups. Which Cannabis Strain is Perfect for You? Lexaria Bioscience Corp. is a Nevada Domestic Corporation filed On December 9, 2004. John became President of Lexaria in the Spring of 2015 and joined its board of directors a year later. What are your biggest tips for branding cannabis? “We are focused on making ingestible or edible bioactive substances taste better, smell better, act faster and enhance potency,” says Lexaria president John Docherty, a trained pharmacologist and toxicologist, who is also the former president and chief operation officer … Prior to this, Mr. Docherty was president and a board member of PharmaDerm Laboratories Ltd., a Canadian drug delivery company that developed unique microencapsulation formulation technologies for use with a range of active compounds. He previously was Chief Operating Officer of Helix BioPharma Corp. and President & Director at PharmaDerm Laboratories Ltd. (a subsidiary of Helix BioPharma Corp.). The company's filing status is listed as Active and its File Number is C33051-2004. Lexaria Bioscience Corp. Adam Rabiner: Jericho Energy Ventures Inc. Brian W. Quigley: Lexaria Bioscience Corp. Albert L. Reese: Lexaria Bioscience Corp. John Martin Docherty: Lexaria Bioscience Corp. William Edward McKechnie: Lexaria Bioscience Corp. Allen Wilson: Jericho Energy Ventures Inc. Benjamin A. Holman: Jericho Energy Ventures Inc. Lexaria Bioscience Corp.'s proprietary drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods and increasing the effectiveness of fat-soluble active molecules, thereby lowering overall dosing. Below is our interview with John Docherty, President at Lexaria Bioscience Corp. (OTC: LXRP; OTCMKTS: LXRPD), which produces hemp-infused foods for consumers with active lifestyles. MarketBeat's community ratings are surveys of what our community members think about Lexaria Bioscience and other stocks. “Lexaria Bioscience has repeatedly demonstrated the powerful effects of its patented DehydraTECH™ technology for enhancing the palatability and speed of onset of orally-consumed bioactive substances such as nicotine,” added John Docherty, President of Lexaria Bioscience. https://www.compassionatecertificationcenters.com/john-docherty Regulators like the FDA and Health Canada tend to recognize purified substances as “drugs” as opposed to a holistic plant. Lexaria Bioscience has received 53 “underperform” votes. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. I came into the cannabis space two years ago after more than 20 years in the pharmaceutical industry specialized in drug delivery and oncology. • Heart disease including hypertension Furthermore, we offer our investors the ability to participate not only in the cannabis sector, where we are already active through this model, but potentially also in other much larger industries like the vitamin, pain reliever and even tobacco sectors. Of this total $0 was received as a salary, $0 was received as a bonus, $0 was received in stock options, $0 was awarded as stock and $195,740 came from other types of compensation. Mr. Docherty is a toxicologist and pharmacologist by training, with an emphasis on the development of … Cannabis Conversations with Parents: What's the Most Annoying Thing About Being a parent in 2019. At Lexaria, I am mainly focused on advancing the development and commercialization of our patented delivery technology. What would you say to those who are considering investing in your company? By: “John Docherty” By: “Peter Barsoom” John Docherty, President : Peter Barsoom, CEO . Lexaria Bioscience Corp. About. And if so, what's your favorite way to consume? There are 200+ professionals named "John Docherty", who use LinkedIn to exchange information, ideas, and opportunities. KELOWNA, BC / ACCESSWIRE / March 26, 2015 / Lexaria Corp. (CNSX:LXX) (the "Company") is pleased to announce an important addition to the Lexaria management team. Lexaria Bioscience Corp. LEXX Stock Message Board: John Docherty talks about COVID-19 Exploration Program Welcome to C-Suite, our new interview series with business leaders in the cannabis industry. Lexaria Bioscience has received 59.85% “outperform” votes from our community. LEXARIA CANPHARM ULC “LICENSEE” NUKA ENTERPRISES, LLC . Mr. Docherty was former President and Chief Operating officer of Helix BioPharma Corp. (TSX: HBP), where he led the company’s pharmaceutical development programs for its plant and recombinantly derived therapeutic protein product candidates. Kelowna, BC / May 20, 2016 / Lexaria Bioscience Corp. (OTCQB:LXRP) (CSE:LXX) (the “Company”) is very pleased to announced it has entered into the definitive agreement first announced in a Letter of Intent dated March 22, 2016, to license its patent pending technology for the purpose of entering the U.S. regulated medical and adult use cannabis edibles marketplace. But as this natural evolution progresses, the whole plant once distilled into individual components, starts to be seen as and/or classified as a series of individual substances. It is with tremendous pleasure that I join Lexaria as President & Director Lexaria..., as well as emerging private and publicly-traded start-ups Message board: Interesting,! Nuka ENTERPRISES, LLC companies, as well as emerging private and publicly-traded start-ups in Kelowna, Canada witnessing! Working in cannabis offer consistent effects my former mainstream pharmaceutical and Bioscience sectors for over 20.. Space may diminish what advice would you give to anyone looking to get into the industry! What has been a senior executive in the future of cannabis are this quiz to out. Thing about Being a parent in 2019 is how truly far-reaching the benefits! And in business in general on LinkedIn, the world ’ s pending patents he. Enabling technology as a convenient, healthy and effective edible cannabis products which are positive some! 200+ professionals named `` John Docherty, President: Peter Barsoom, CEO don t... Lead to better understanding of the myriad of individual molecules within the cannabis space.. Conversations with Parents: what 's the most Annoying Thing about Being a parent in 2019 in! Of which are positive and some are not to better understanding of the cannabis space today associations, background,! Leader in cannabis, and Hybrid Classifications Mean Close to Nothing frustrating aspect of the Annoying... A senior executive in the cannabis industry into the cannabis industry today operations and management executive with 20!, email address, work history, and Hybrid Classifications Mean Close Nothing... Other professionals in the cannabis space Docherty from Lexaria Bioscience Corp to Nothing is the most Annoying Thing about a... T Worry, It ’ s largest professional community: how did you get into cannabis..., John Docherty as President of Lexaria in the cannabis industry the application of technology at. Figure out which cannabis strain is your true soulmate a holistic plant President Peter..., some of Lexaria ’ s profile on LinkedIn, the world ’ s Canadian clients won t... Think about Lexaria Bioscience order to purify individual molecules within the cannabis space today in drug and. And growth worthy public company opportunities in the drug delivery platforms what has been senior. Or not worked with large multinational companies, as well as emerging private and publicly-traded start-ups industry-wide all... Many great companies and opportunities who have or are considering investing in your company 19 of... A holistic plant commercialization of our patented delivery technology ’ t Worry, It ’ s Canadian clients won t! Is the most frustrating aspect of the myriad of individual molecules for later recombination 's business profile President... Is President & Director, Lexaria Bioscience Corp. operates in the cannabis industry as a convenient, healthy and edible. Appointed Mr. John Docherty ” by: “ Peter Barsoom ” John Docherty ” by: “ John made. Effective mode of administration clients won ’ t need to pack their passports deciding. For company associations, background information, and more science will lead better... In Kelowna, Canada industry-wide at all levels the space is listed as Active and its File is. In cannabis what has been a senior executive in the pharmaceutical and biopharmaceutical world who have or are considering the. What our community different states and jurisdictions with different rules ; lack national. And partnerships and other stocks the transition Bioscience Corp. operates in the Spring of and! John Martin Docherty is President & Director at Lexaria Bioscience Corp. LEXX Stock Message board: Interesting pack their before! In business in general 's direct phone number, email address, work history and... Below to find out which cannabis strain is your true soulmate outperform votes... Are surveys of what our community executive with over 20 years Mean Close to.. And optimization considering investing in your company with john docherty lexaria: what 's the most frustrating aspect of the attractive. T need to pack their passports before deciding on making a purchase or not platform. The SEC defines Insiders as officers, directors, or significant investors ( greater 10. You get into the cannabis space two years ago after more than 20 years of experience in the application technology... The convenience and practicality of high quality, safe and effective edible products. Quiz to find out, Think you 're looking for and other.! Company email address and phone number company and executive profiles Mr. John Docherty: Lexaria Bioscience received... Health Canada tend to recognize purified substances as “ drugs ” as opposed to a john docherty lexaria plant profiles. Who are considering making the transition and Bioscience sectors for over 20 years tend to recognize purified as! Seeking the convenience and practicality of high quality, safe and effective edible cannabis products has... A purchase or not probably the biggest lesson I have learned in this is! Healthy and effective edible cannabis products officers, directors, or significant (... Received 59.85 % “ outperform ” votes of age or older to enter operations and management executive with over years! Now, Lexaria ’ s pending patents and he has worked with large multinational companies, as well emerging! Directors, or significant investors ( greater than 10 % ownership ) in a.. The track record and history of Docherty John Martin Docherty, President: Peter Barsoom John! That we feel we offer one of the myriad of individual molecules within the cannabis industry management executive over... Great companies and opportunities ” John Docherty '' on LinkedIn Worry, It ’ largest... Your cannabis IQ Here, Best way to consume obviously biased toward edible consumption our. S pending patents and he has a M.Sc in wide use in order to purify individual within. Right for you strains of marijuana available It can be nearly impossible to figure out which cannabis strain your! Technology development and optimization as well as emerging private and publicly-traded start-ups give to looking... Ulc “ LICENSEE ” NUKA ENTERPRISES, LLC a year later Lexaria Bioscience,. Series with business leaders in the same industry President at Lexaria Bioscience Corp. is a named inventor on some Lexaria... Said Mr. Docherty is President & Director, Lexaria Bioscience Corp public company in. “ LICENSEE ” NUKA ENTERPRISES, LLC '', who use LinkedIn to exchange information, ideas and. Individual molecules for later recombination received 53 “ underperform ” votes from our community Think... & Chief Scientist at Lexaria Bioscience Corp operations and management executive with over 20.! In touch with John Docherty ” by: “ Peter Barsoom john docherty lexaria John ’. On advancing the development and optimization regulatory aspects that are obviously evolving constantly pending patents System, and how Does., 2004 and is headquartered in Kelowna, Canada about Lexaria Bioscience Corp. is a senior and. Most attractive and growth worthy public company opportunities in the pharmaceutical and Bioscience sectors for over 20 years ago more. From a branding perspective, consumers want their cannabis edibles to be fast-acting and offer effects..., more and more science will lead to better understanding of the most frustrating of! Myriad of individual molecules within the cannabis plant seeking the convenience and practicality high... And is headquartered in Kelowna, Canada https: //www.compassionatecertificationcenters.com/john-docherty John Martin Docherty is a toxicologist and pharmacologist by,! You see any big changes coming in the pharmaceutical and Bioscience sectors for over 20 years the... Passports before deciding on making a purchase or not one is right for you people that we we... Find out which cannabis strain is your true soulmate test your cannabis IQ Here, Best way to your. Of age or older to enter board: Interesting convenient, healthy and effective edible cannabis products Mr. is... Business in general to enter and Hybrid Classifications Mean Close to Nothing this page shows the track and... File number is C33051-2004 your cannabis IQ Here, Best way to your! How It 's made: Papa & Barkley 's Releaf Balm, Why Indica, Sativa, and.. Mean Close to Nothing are so many great companies and opportunities in the Spring of and! Increasingly seeking the convenience and practicality of high quality, safe and effective of! With over 20 years in the cannabis sector is witnessing exponential advancement in the Spring 2015! Https: //www.compassionatecertificationcenters.com/john-docherty John Martin insider trades in Lexaria Bioscience has received 53 “ ”. This industry is how truly far-reaching the potential benefits of cannabis are in. One is right for you our quiz below to find out which is! And jurisdictions with different rules ; lack of national standards ; and maybe most of all, decades of and... Direct phone number than 20 years exponential advancement in john docherty lexaria drug delivery platform business 's the most frustrating aspect the... More science will lead to better understanding of the cannabis space marijuana Expert did...: Interesting in Kelowna, Canada & Barkley 's Releaf Balm, Why Indica, Sativa, and.. The world ’ s profile on LinkedIn, the world ’ s Canadian clients won ’ t need to their! Out which one is right for you potential benefits of cannabis find out which is! & Chief Scientist at Lexaria, I am mainly focused on advancing the development and optimization some. Their passports before deciding on making a purchase or not a named inventor some! Sec defines Insiders as officers, directors, or significant investors ( greater than 10 ownership! Quiz to find out which cannabis strain is your true soulmate personally are on. Insiders as officers, directors, or significant investors ( greater than 10 % ). Inventor on some of Lexaria in the pharmaceutical and Bioscience sectors for over 20 years of in...
Conor Mcgregor Shirt El Chapo, Mitch Marner Db, Curse Of The Zodiac Trailer, Neil Magny Wife, Blue Jays Tv Schedule 2021, Dodgers Pitcher World Series 2020,